Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2022 Jul 27;22:822. doi: 10.1186/s12885-022-09836-2

Correction: Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses

Kun Zhang 1, Ke Wang 1, Chaoguo Zhang 1, Xiuli Teng 1, Dan Li 1, Mingwei Chen 1,
PMCID: PMC9326412  PMID: 35896984

Correction: BMC Cancer 22, 687 (2022)

https://doi.org/10.1186/s12885-022-09763-2

Following publication of the original article [1], the authors identified a production error. Figure 8 was not correctly processed by the publisher. The correct version of figure 8 is supplied in this correction article.

Fig. 8.

Fig. 8

RMSD and RMSF of the SARS-CoV-2 Mpro complexes and DDP4 complexes. A The RMSD of Mpro. B The RMSD of DDP4. C The RMSD of inhibitor 11a and emetine. D The RMSD of omarigliptin and emetine. E The RMSF of Mpro. F The RMSF of DDP4

Reference

  • 1.Zhang K, Wang K, Zhang C, et al. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer. 2022;22:687. doi: 10.1186/s12885-022-09763-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES